Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IL23R | Q5VWK5 | 13/20 | 0.51 |
| ▸ | OPRL1 | P41146 | 3/20 | 0.48 |
| ▸ | TFPI | P10646 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23057565 | 1.00 | IL23R (0.51) | IL23ROPRL1TFPI | |
| SCHEMBL16349703 | 0.97 | IL23R (0.50) | IL23ROPRL1TFPI | |
| SCHEMBL22003315 | 0.96 | IL23R (0.48) | IL23ROPRL1TFPI | |
| SCHEMBL12082890 | 0.95 | IL23R (0.50) | IL23ROPRL1TFPI | |
| SCHEMBL31181281 | 0.94 | IL23R (0.50) | IL23ROPRL1TFPI | |
| SCHEMBL13703199 | 0.93 | IL23R (0.51) | IL23ROPRL1 | |
| SCHEMBL22382220 | 0.93 | IL23R (0.51) | IL23ROPRL1 | |
| SCHEMBL13659872 | 0.92 | IL23R (0.52) | IL23R | |
| SCHEMBL13870329 | 0.92 | IL23R (0.54) | IL23R | |
| SCHEMBL10046332 | 0.92 | IL23R (0.52) | IL23R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025233638-A1 | RADIOPHARMACEUTICAL IMAGING METHOD OF ADENOMYOSIS | SERAC HEALTHCARE LTD (GB) | 2025-11-13 | — | — | WO | disclosed |
| US-20250186633-A1 | METHODS FOR IMAGING INTEGRIN EXPRESSION AND FOR IMAGING SITES OF ENDOMETRIOSIS | SERAC HEALTHCARE LTD (GB) | 2025-06-12 | — | — | US | disclosed |
| EP-4486396-A1 | METHODS FOR IMAGING INTEGRIN EXPRESSION AND FOR IMAGING SITES OF ENDOMETRIOSIS | Serac Healthcare Ltd (GB) | 2025-01-08 | — | — | EP | disclosed |
| WO-2023166305-A1 | METHODS FOR IMAGING INTEGRIN EXPRESSION AND FOR IMAGING SITES OF ENDOMETRIOSIS | SERAC HEALTHCARE LTD (GB) | 2023-09-07 | — | — | WO | disclosed |
| US-11723991-B2 | Radiopharmaceutical compositions | SERAC HEALTHCARE LIMITED (GB) | 2023-08-15 | — | — | US | disclosed |
| US-10758635-B2 | Radiopharmaceutical compositions | SERAC HEALTHCARE LIMITED (GB) | 2020-09-01 | — | — | US | disclosed |
| US-20130129623-A1 | RADIOPHARMACEUTICAL COMPOSITIONS | GE HEALTHCARE LIMTED (GB) | 2013-05-23 | — | — | US | disclosed |
| US-8299030-B2 | Peptide-based compounds | GE HEALTHCARE LIMITED (GB) | 2012-10-30 | — | — | US | disclosed |
| US-20120020882-A1 | PEPTIDE-BASED COMPOUNDS | GE HEALTHCARE AS (NO) | 2012-01-26 | — | — | US | disclosed |
| US-7994134-B2 | Peptide-based compounds | GE HEALTHCARE AS (NO) | 2011-08-09 | — | — | US | disclosed |
| US-7994134-B2 | Peptide-based compounds | GE HEALTHCARE AS (NO) | 2011-08-09 | — | — | US | disclosed |
| US-20090203584-A1 | Peptide-based Compounds | GE HEALTHCARE LIMITED (GB) | 2009-08-13 | — | — | US | disclosed |
| US-20090203584-A1 | Peptide-based Compounds | GE HEALTHCARE LIMITED (GB) | 2009-08-13 | — | — | US | disclosed |
| US-7521419-B2 | Peptide-based compounds | GE HEALTHCARE AS (NO) | 2009-04-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090203584-A1 | Peptide-based Compounds | ITGB3, ITGAV, SELPLG | IL23R 973/4885OPRL1 541/4885TFPI 717/4885 |
| US-11723991-B2 | Radiopharmaceutical compositions | TYMP, KIT, CHEK1 | IL23R 2328/4885OPRL1 2460/4885TFPI 3207/4885 |
| US-20250186633-A1 | METHODS FOR IMAGING INTEGRIN EXPRESSION AND FOR IMAGING SITES OF ENDOMETRIOSIS | ITGB3, ITGB5, ITGAV | IL23R 1584/4885OPRL1 537/4885TFPI 1272/4885 |
| US-10758635-B2 | Radiopharmaceutical compositions | TYMP, KIT, CHEK1 | IL23R 2324/4885OPRL1 2633/4885TFPI 3310/4885 |
| US-20120020882-A1 | PEPTIDE-BASED COMPOUNDS | ITGB3, ITGAV, SELPLG | IL23R 973/4885OPRL1 541/4885TFPI 717/4885 |
| US-20130129623-A1 | RADIOPHARMACEUTICAL COMPOSITIONS | TYMP, KIT, CHEK1 | IL23R 2324/4885OPRL1 2633/4885TFPI 3310/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.